For first time, FDA approves marketing of nicotine pouch products
The U.S. Food and Drug Administration on Thursday okayed the marketing of 20 Zyn nicotine pouch products after undertaking an ...
FDA 'Closely Monitoring' Zyn Nicotine Pouches After Marketing Approval
The Food and Drug Administration (FDA) announced on Thursday that it authorized the marketing of Zyn nicotine pouches but ...
FDA authorizes Zyn nicotine pouches, cites lower risk than cigarettes
The FDA authorized the marketing of 20 Zyn products on Thursday, marking the first allowance for the fast-growing nicotine ...
Outgoing FDA Chief Flags Online Weight Loss Drug Dangers
Novo Nordisk's and Eli Lilly's weight loss drugs can cost over $1,000 for a month's supply, while compounded versions ...
US FDA officially authorises Zyn nicotine pouches for sale
The pouches are used by less than 2% of US teens, the FDA said in granting the application allowing them to continue to be ...
FDA OKs sales of Zyn nicotine pouches, citing health benefits for adult smokers
Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris ...
What Foods Will Be Impacted by FDA’s Ban on Red Dye No. 3—And What Could Replace It
T he U.S. Food and Drug Administration (FDA) banned the use of Red Dye No. 3 in food and ingested drugs on Wednesday, more ...
FDA Proposes Nicotine Cap To Help Curb Cigarette Addiction
The rule proposes a maximum nicotine level of 0.7 milligrams (mg) per gram of tobacco -- a significant decrease from current ...
FDA bans red dye No. 3 from foods
U.S. regulators are banning the dye called Red 3 from the food supply. The move comes nearly 35 years after the dye was ...
Denver health experts, parents support FDA move to ban Red 3
On Wednesday, the FDA announced a ban on Red 3 from store shelves in response to animal testing studies linking the ...
Yogurt Recall Update As FDA Sets Risk Level Over Plastic Contamination
Greek yogurt has been recalled because it may contain foreign objects, given the FDA's second-most severe risk level.